ArticleRheumatology (Oxford, England)2022

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.

Laura Pina Vegas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.